Target intelligence / Profile preview

Adrenergic Receptor Alpha2C (ADRA2C)

Target
ADRA2C
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

The adrenergic receptor alpha2C (α2C adrenoceptor), also known as ADRA2C, is one of three highly homologous subtypes of the alpha-2 adrenergic receptors. These G protein-coupled receptors (GPCRs) are critical regulators of neurotransmitter release from sympathetic nerves and central adrenergic neurons. The α2C receptor is primarily localized in the central nervous system, with notable expression in areas such as the midbrain, thalamus, amygdala, and cortex. Upon activation, α2C receptors couple to Gi proteins, inhibiting adenylyl cyclase and reducing cAMP levels, leading to hyperpolarization of neurons and decreased neurotransmitter release. This receptor plays a crucial role in fine-tuning neurotransmission, particularly during low-level neuronal activity, making it a target for drugs affecting mood disorders, cardiovascular function, pain modulation, and sedation/anxiolysis therapies.

Other names
alpha2C adrenoceptor
02

Mechanism of action

Gi-protein mediated inhibition of adenylyl cyclase

03

Biological functions

Modulation of neurotransmitter releaseRegulation of CNS toneInhibition of adenylyl cyclase activitySignal transduction
04

Disease associations

Mood disordersCardiovascular dysfunctionPainAnxiety
05

Safety considerations

SedationAnalgesiaSympatholytic effectsReductions in heart rate/blood pressureAttenuation of stress responses
06

Interacting drugs

(R)-3-Nitrobiphenyline

9 more in the full profile.

Beyond the preview

Go deeper on Adrenergic Receptor Alpha2C (ADRA2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adrenergic Receptor Alpha2C (ADRA2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call